Update on the Prenatal Diagnosis and Outcomes of Fetal Bilateral Renal Agenesis.


Journal

Obstetrical & gynecological survey
ISSN: 1533-9866
Titre abrégé: Obstet Gynecol Surv
Pays: United States
ID NLM: 0401007

Informations de publication

Date de publication:
May 2019
Historique:
entrez: 18 5 2019
pubmed: 18 5 2019
medline: 25 12 2019
Statut: ppublish

Résumé

Bilateral renal agenesis is a rare congenital anomaly associated with poor prognosis. The aims of this article are to review and summarize evidence on prenatal diagnosis and outcomes of bilateral renal agenesis. A search was undertaken using PubMed and ClinicalTrials.gov databases from January 1, 1998, to September 1, 2018. Search terms include "prenatal diagnosis" OR "outcomes" AND "bilateral renal agenesis." Search was limited to English language. Fetal ultrasonography is the primary imaging modality for prenatal diagnosis of fetal urogenital tract abnormalities. However, ultrasonography is limited by several factors; it is operator dependent and associated with small field of view, has limited soft-tissue acoustic contrast, and is also influenced by patient habitus and fetal position. Color Doppler ultrasonography can be used as an adjunct to exclude bilateral renal agenesis by visualizing renal arteries. In the literature, prenatal magnetic resonance imaging has been reported to be equal to or superior to prenatal ultrasonography. Bilateral renal agenesis with oligohydramnios/anhydramnios is associated with a poor prognosis; perinatal death occurs secondary to pulmonary hypoplasia in the majority of cases. Ultrasonography in combination with color Doppler ultrasonography permits the fetal urinary tract to be assessed in the first and early second trimester of gestation. The magnetic resonance imaging can be used as a complementary adjunctive modality in equivocal or inconclusive ultrasonographic findings.

Identifiants

pubmed: 31098643
doi: 10.1097/OGX.0000000000000670
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

298-302

Auteurs

Carola Huber (C)

Medical Student, Medical University of Graz, Graz, Austria; Research Trainee.

Sherif A Shazly (SA)

Resident in Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN.

Yair J Blumenfeld (YJ)

Associate Professor and Director of Fetal Therapy, Division of Maternal-Fetal Medicine and Obstetrics, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA.

Eric Jelin (E)

Assistant Professor and Director of Johns Hopkins Children's Center Fetal Program, Division of Pediatric Surgery, The Johns Hopkins Hospital, Baltimore, MD.

Rodrigo Ruano (R)

Professor of Obstetrics & Gynecology, Pediatrics and Physiology & Biomedical Engineering, Chair of the Division of Maternal-Fetal Medicine, and Director of Mayo Clinic Fetal Section, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH